Neurelis, Inc.
4 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Study of Olanzapine After Intranasal and Intramuscular Administration (NCT06600477) | Neurelis, Inc. | 2023-10-16 |
| Pharmacokinetics Study of VALTOCO® in Pediatric Subjects With Epilepsy (NCT05076838) | Neurelis, Inc. | 2021-11-08 |
Track Neurelis, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.